Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (321-330 of 437) with videos related to

Pageof 44
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Leukemia Research|December 28, 2007
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptorJianbiao Zhou, Jiaying Khng, Viraj J Jasinghe, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitorsD H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bone Marrow Transplantation|May 10, 2011
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patientsM Mynarek, J Tolar, M H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Journal of Clinical Immunology|August 21, 2024
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party StudyDagmar Berghuis, Lubna S Mehyar, Rolla Abu-Arja, et al.
Pageof 44

Showing results (321-330 of 437) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trialPeter Bader, Hermann Kreyenberg, Arend von Stackelberg, et al.
Leukemia Research|December 28, 2007
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptorJianbiao Zhou, Jiaying Khng, Viraj J Jasinghe, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitorsD H Steinman, M L Curtin, R B Garland, et al.
Journal of Enzyme Inhibition|October 28, 1999
Evaluation of the inhibition of other metalloproteinases by matrix metalloproteinase inhibitorsP A Marcotte, I N Elmore, Z Guan, et al.
Bone Marrow Transplantation|May 10, 2011
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patientsM Mynarek, J Tolar, M H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitorsYujia Dai, Kresna Hartandi, Niru B Soni, et al.
Blood|January 25, 2015
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCTJudith Feucht, Kathrin Opherk, Peter Lang, et al.
British Journal of Haematology|January 8, 2026
Equal outcomes after human leukocyte antigen-matched unrelated versus sibling donor transplants-Results of the AML SCT-BFM 2007 trial and consecutive 'real-world routine'Martin G Sauer, Peter J Lang, Michael H Albert, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2006
Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
Journal of Clinical Immunology|August 21, 2024
Allogeneic Hematopoietic Stem Cell Transplantation in Immunodeficiency-Centromeric Instability-Facial Dysmorphism (ICF) Syndrome: an EBMT/ESID Inborn Errors Working Party StudyDagmar Berghuis, Lubna S Mehyar, Rolla Abu-Arja, et al.
Pageof 44